BioNTech SE (BNTX)
After hours:
| Previous close | 101.93 |
| Open | 101.19 |
| Bid | 103.40 x 800 |
| Ask | 103.52 x 800 |
| Day's range | 100.75 - 103.62 |
| 52-week range | 88.00 - 188.99 |
| Volume | |
| Avg. volume | 656,235 |
| Market cap | 24.8B |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | 5.43 |
| EPS (TTM) | 19.04 |
| Earnings date | 06 Nov 2023 |
| Forward dividend & yield | 2.11 (1.32%) |
| Ex-dividend date | 02 June 2022 |
| 1y target est | 139.39 |
Insider Monkey12 Best Healthcare Stocks For the Long-Term
In this piece, we will take a look at the 12 best healthcare stocks for the long term. If you want to skip our overview of the healthcare industry, then you can take a look at 5 Best Healthcare Stocks For the Long-Term. The healthcare industry is one of the biggest industries in the world. […]
Insider MonkeyDo You Think the Decrease in Demand for COVID-19 Vaccine Boosters Impacted BioNTech SE (BNTX)?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. Inflation remained on a downward trend in the quarter and the fund’s Investor Class fund ARTMX returned -2.95%, Advisor Class fund APDMX posted a return of -2.92%, and Institutional Class […]
- Investing.com
BioNTech ADRs drop after JPMorgan lowers outlook to "underweight"
Investing.com -- U.S.-listed shares in BioNTech (NASDAQ:BNTX) dipped in early trading on Friday after analysts at JPMorgan downgraded their rating of the vaccine maker to "underweight" from "neutral."
